.svg){kind=small}
Sep-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Canna Clinicals has shown a consistent presence in the Tincture & Sublingual category in New York. Over the months from June to September 2024, the brand maintained a position within the top 10, although there was a slight decline from 5th to 7th place. This movement indicates a competitive market environment, where maintaining a top position requires constant innovation and marketing efforts. The brand's sales figures reveal some fluctuations, with a notable drop in July but a recovery in August, suggesting that seasonal factors or promotional activities might have influenced consumer purchasing behavior.
In other states, Canna Clinicals did not appear in the top 30 brands for the Tincture & Sublingual category, which could be a cause for concern or an opportunity for growth, depending on the brand's strategic objectives. The absence from these rankings highlights potential areas for market expansion or increased brand awareness efforts. It is crucial for Canna Clinicals to analyze these markets to understand the local consumer preferences and competitive landscape better, which could inform their strategies to improve visibility and ranking in these regions.
Competitive Landscape
In the competitive landscape of the Tincture & Sublingual category in New York, Canna Clinicals has experienced a slight decline in its market position over the past few months. Starting from a strong 5th place in June 2024, Canna Clinicals dropped to 6th in July and August, and further to 7th in September. This downward trend contrasts with the stability of Veterans Choice Creations (VCC), which maintained its 5th rank from July through September, indicating a consistent performance. Meanwhile, Harney Brothers Cannabis showed a recovery from being unranked in July to climbing back to 6th place in September. These shifts suggest that while Canna Clinicals has a strong presence, it faces increasing competition from brands like VCC and Harney Brothers, which could impact its sales momentum if the trend continues.
Notable Products
In September 2024, Canna Clinicals' top-performing product was the CBD/THC 1:10 Max Strength Tincture, maintaining its consistent first-place ranking since June, with sales reaching 198 units. The Max Strength Capsules 10-Pack held steady in second place, similar to its performance in previous months. The CBD/THC/CBG 1:1:1 Relief Complex Capsules maintained their third-place position from August, indicating a stable demand. Notably, the CBD/THC Balance Tincture, which had ranked third in June, did not appear in the top rankings for September. The CBD/THC/CBN 1:1:1 Sleep Complex Capsules, previously ranked third in July, were not listed in the September rankings, suggesting a shift in consumer preferences towards other products.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
